RESUMEN
BACKGROUND: One-third of people with depression do not respond to antidepressants, and, after two adequate courses of antidepressants, are classified as having treatment-resistant depression (TRD). Some case reports suggest that ketogenic diets (KDs) may improve some mental illnesses, and preclinical data indicate that KDs can influence brain reward signalling, anhedonia, cortisol, and gut microbiome which are associated with depression. To date, no trials have examined the clinical effect of a KD on TRD. METHODS: This is a proof-of-concept randomised controlled trial to investigate the efficacy of a six-week programme of weekly dietitian counselling plus provision of KD meals, compared with an intervention involving similar dietetic contact time and promoting a healthy diet with increased vegetable consumption and reduction in saturated fat, plus food vouchers to purchase healthier items. At 12 weeks we will assess whether participants have continued to follow the assigned diet. The primary outcome is the difference between groups in the change in Patient Health Questionnaire-9 (PHQ-9) score from baseline to 6 weeks. PHQ-9 will be measured at weeks 2, 4, 6 and 12. The secondary outcomes are the differences between groups in the change in remission of depression, change in anxiety score, functioning ability, quality of life, cognitive performance, reward sensitivity, and anhedonia from baseline to 6 and 12 weeks. We will also assess whether changes in reward sensitivity, anhedonia, cortisol awakening response and gut microbiome may explain any changes in depression severity. DISCUSSION: This study will test whether a ketogenic diet is an effective intervention to reduce the severity of depression, anxiety and improve quality of life and functioning ability for people with treatment-resistant depression.
Asunto(s)
Trastorno Depresivo Resistente al Tratamiento , Dieta Cetogénica , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adulto Joven , Terapia Combinada , Trastorno Depresivo Resistente al Tratamiento/dietoterapia , Trastorno Depresivo Resistente al Tratamiento/terapia , Evaluación de Resultado en la Atención de Salud , Prueba de Estudio Conceptual , Ensayos Clínicos Controlados Aleatorios como AsuntoRESUMEN
Cada vez hay más evidencia que demuestra el papel de los nutrientes en la salud mental. Una adecuada alimentación contribuye a una mejor salud general y salud mental en particular. La depresión mayor es una enfermedad mental grave con una alta prevalencia para la que existen tratamientos eficaces pero no en todos los casos se consigue la remisión del paciente. Por ello, cada vez se apunta más hacia la optimización en la aportación de nutrientes necesarios para un adecuado funcionamiento cerebral como terapia coadyuvante al tratamiento antidepresivo. En este artículo revisamos aquellos nutrientes sobre los que se ha estudiado su implicación en dicha patología: ácidos grasos omega-3, vitaminas del grupo B, s-adenosilmetionina, triptófano, magnesio, zinc y probióticos (AU)
There is increasing evidence about the role of nutrients in mental health. An adequate intake of nutrients contributes to better overall health and mental health in particular. Major depression is a severe mental illness with a high prevalence for which effective treatments exist but not in all cases the patients remission is achieved. Therefore, it is increasingly aimed at optimizing the supply of nutrients necessary for adequate brain functioning as adjunctive therapy to antidepressant treatment in depressive disorders. In this article we review those nutrients that have been related to depression: Omega-3 fatty acids, B vitamins, s-adenosylmethionine, tryptophan, magnesium, zinc and probiotics (AU)